Afya (AFYA) to Release Quarterly Earnings on Thursday

Afya (NASDAQ:AFYA) is expected to issue its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of $0.36 per share and revenue of $174.7420 million for the quarter. Parties may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, March 12, 2026 at 5:00 PM ET.

Afya Price Performance

AFYA stock opened at $13.44 on Thursday. The company’s 50-day moving average price is $14.57 and its two-hundred day moving average price is $14.82. The firm has a market cap of $1.26 billion, a P/E ratio of 9.67, a P/E/G ratio of 0.64 and a beta of 0.52. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.21. Afya has a 12 month low of $13.00 and a 12 month high of $19.90.

Analysts Set New Price Targets

AFYA has been the topic of a number of recent analyst reports. Zacks Research cut shares of Afya from a “hold” rating to a “strong sell” rating in a research note on Friday, January 9th. UBS Group reiterated a “neutral” rating and issued a $16.00 price target (down from $18.00) on shares of Afya in a research note on Friday, January 16th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $22.00 price target (down from $24.50) on shares of Afya in a report on Wednesday, January 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research note on Wednesday, January 21st. Finally, Wall Street Zen cut Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 31st. One equities research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $17.30.

Hedge Funds Weigh In On Afya

Large investors have recently bought and sold shares of the company. State Street Corp grew its holdings in shares of Afya by 25.8% during the fourth quarter. State Street Corp now owns 126,914 shares of the company’s stock worth $1,955,000 after purchasing an additional 26,005 shares during the last quarter. Bank of America Corp DE boosted its position in Afya by 11.9% during the 2nd quarter. Bank of America Corp DE now owns 86,201 shares of the company’s stock worth $1,540,000 after buying an additional 9,192 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in Afya by 5.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock worth $1,217,000 after acquiring an additional 3,626 shares during the last quarter. Geode Capital Management LLC increased its position in Afya by 16.6% in the 4th quarter. Geode Capital Management LLC now owns 60,378 shares of the company’s stock valued at $930,000 after acquiring an additional 8,610 shares during the period. Finally, PDT Partners LLC increased its position in Afya by 50.7% in the 2nd quarter. PDT Partners LLC now owns 51,439 shares of the company’s stock valued at $919,000 after acquiring an additional 17,307 shares during the period. 88.02% of the stock is currently owned by institutional investors.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.